Qualigen Therapeutics, Inc.
QLGN
$3.11
$0.103.32%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 227.04% | 27.36% | -76.80% | -80.62% | 54.57% |
| Total Receivables | -- | -- | -- | -- | -65.35% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 50.78% | -9.63% | -39.87% | -32.91% | -9.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 332.82% | -46.73% | -14.02% | -66.18% | -29.06% |
|
|
|||||
| Total Current Assets | 332.82% | -46.73% | -14.02% | -66.18% | -29.06% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | 0.00% | 3,540.76% |
| Total Assets | 332.82% | -46.73% | -50.66% | -52.89% | -67.18% |
|
|
|||||
| Total Accounts Payable | -11.62% | 2.92% | -18.97% | 41.43% | -10.50% |
| Total Accrued Expenses | -39.41% | 13.97% | 47.90% | -56.26% | -36.65% |
| Short-term Debt | -14.12% | 63.26% | -21.27% | 56.14% | -53.19% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 127.75% | -59.42% | 1,294.49% | -97.23% | -15.52% |
| Total Other Current Liabilities | 127.75% | -59.42% | 1,294.49% | -97.23% | -15.52% |
| Total Current Liabilities | -7.45% | 6.35% | 9.38% | -30.55% | -29.87% |
|
|
|||||
| Total Current Liabilities | -7.45% | 6.35% | 9.38% | -30.55% | -29.87% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -14.12% | 63.26% | -21.27% | 56.14% | -53.19% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -7.45% | 6.35% | 9.38% | -30.55% | -39.47% |
|
|
|||||
| Common Stock & APIC | 3.38% | 0.71% | 0.54% | 1.76% | 0.10% |
| Retained Earnings | -1.49% | -1.33% | -1.74% | -2.14% | -3.30% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 49.95% | -21.47% | -67.41% | -28.22% | -180.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 49.95% | -21.47% | -67.41% | -28.22% | -180.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 49.95% | -21.47% | -67.41% | -28.22% | -149.59% |
|
|
|||||
